Literature DB >> 6452981

Krypton-81m ventilation scintigraphy for the diagnosis of pulmonary emboli.

M L Goris, S G Daspit.   

Abstract

The value of ventilation studies in conjunction with pulmonary perfusion scintigraphies for the diagnosis of pulmonary emboli is reviewed. A retrospective study of 273 consecutive cases and comparison with 42 angiographic results provides the data base. The data are compared with previously reported results and confirm the diagnostic gain obtained by ventilation studies. Possible advantages of the use of krypton-81m for the ventilation study are suggested. Finally, with the observed prevalence of six possible scintigraphic outcomes and assuming that two outcomes are diagnostic, it can be shown that the addition of a ventilation study in the diagnostic work-up decreases the average cost of the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6452981     DOI: 10.1097/00003072-198105000-00006

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  Scintigraphic evaluation of pulmonary embolism after total hip replacement, using a dry 99mTc-microaerosol for regional ventilation.

Authors:  H Fredin; M Arborelius
Journal:  Eur J Nucl Med       Date:  1982

2.  Ventilation-perfusion patterns in lung diseases (with reference to those observed in pulmonary embolism).

Authors:  H R Ham; R Amir; J Vandevivere
Journal:  Eur J Nucl Med       Date:  1985

3.  99mTc-DTPA and 99mTc-rhenium sulfur aerosol compared as adjuncts to perfusion scintigraphy in patients with suspected pulmonary embolism.

Authors:  P Peltier; J F Chatal
Journal:  Eur J Nucl Med       Date:  1986

4.  Regional distribution of ventilation-perfusion ratios in acute pulmonary embolism.

Authors:  M Meignan; A Harf; L Cinotti
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

5.  Role of ventilation scintigraphy in diagnosis of acute pulmonary embolism: an evaluation using artificial neural networks.

Authors:  Eva Evander; Holger Holst; Andreas Järund; Mattias Ohlsson; Per Wollmer; Karl Aström; Lars Edenbrandt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-14       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.